Cited by 133Cardiovascular Syncope and Autonomic DisordersConnective tissue disorders researchHeart Rate Variability and Autonomic Control

Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome

Open access
Roma, Maria, Marden, Colleen L., De Wandele, Inge, Francomano, Clair A., Rowe, Peter C.·2018·Autonomic Neuroscience

Abstract

Objective To review the association between orthostatic intolerance syndromes and both joint hypermobility and Ehlers-Danlos syndrome, and to propose reasons for identifying hereditary connective tissue disorders in those with orthostatic intolerance in the context of both clinical care and research. Methods We searched the published peer-reviewed medical literature for papers reporting an association between joint hypermobility or Ehlers-Danlos syndrome and orthostatic intolerance. Results We identified 10 relevant papers. Although methodological variability between studies introduces some limitations, the published literature consistently identifies a significantly higher prevalence of orthostatic intolerance symptoms in patients with joint hypermobility or Ehlers-Danlos syndrome than in healthy controls, and a significantly higher prevalence of cardiovascular and autonomic abnormalities both at rest and during orthostatic challenge. Postural tachycardia syndrome is the most commonly recognized circulatory disorder. The severity of orthostatic symptoms in those with EDS correlates with impairments in quality of life. Conclusion There is a strong association between several forms of cardiovascular dysfunction, most notably postural tachycardia syndrome, and joint hypermobility or Ehlers-Danlos syndrome. We propose that recognition of joint hypermobility and Ehlers-Danlos syndrome among those with orthostatic intolerance syndromes has the potential to improve clinical care and the validity of research findings.

Integrity signals

Registry

Crossref · 10.1016/j.autneu.2018.02.006

Cites

Statistics

Nothing to recompute.

Claims the paper makes

0 of 29 cited sources checked · 0 supported · 0 flagged

  • Findingnone given
    § 4.1. Literature summary · p. 5

    Hemodynamic abnormalities are identified in 56-80% of JH/EDS patients in published studies.

    “Hemodynamic abnormalities are identi fi ed in 56 -80% of JH/EDS patients in published studies”
    Quote in the paperNot a substantial claim
  • Findingreasoning
    § A B S T R A C T · p. 1

    The published literature consistently shows a significantly higher prevalence of cardiovascular and autonomic abnormalities both at rest and during orthostatic challenge in patients with joint hypermobility or EDS than in healthy controls.

    “a signi fi cantly higher prevalence of cardiovascular and autonomic abnormalities both at rest and during orthostatic challenge”
    Quote in the paperSubstantial claim
  • Findingnone given
    § 4.1. Literature summary · p. 5

    Higher prevalence rates of hemodynamic abnormalities are reported when orthostatic testing duration exceeds 20 minutes.

    “with higher prevalence rates being reported when the orthostatic testing duration exceeds 20 min.”
    Quote in the paperNot a substantial claim
  • Findingown data
    § A B S T R A C T · p. 1

    The published literature consistently shows a significantly higher prevalence of orthostatic intolerance symptoms in patients with joint hypermobility or EDS than in healthy controls.

    “the published literature consistently identi fi es a signi fi cantly higher prevalence of orthostatic intolerance symptoms in patients with joint hypermobility or Ehlers-Danlos syndrome than in healthy controls”
    Quote in the paperSubstantial claim
  • Findingnone given
    § A B S T R A C T · p. 1

    There is a strong association between several forms of cardiovascular dysfunction, most notably POTS, and joint hypermobility or EDS.

    “There is a strong association between several forms of cardiovascular dysfunction, most notably postural tachycardia syndrome, and joint hypermobility or Ehlers-Danlos syndrome.”
    Quote in the paperSubstantial claim
  • May combine two claims. 13
  • Classified as probably not a substantial claim. 7
  • The quote only partly states this claim. 1
  • May combine two claims.

    Findingreasoning
    § 4.1. Literature summary · p. 5

    In all studies with more than 10 patients, the data are consistent with clinically important and statistically significant increases in the prevalence of orthostatic symptoms and objective hemodynamic abnormalities in those with joint hypermobility or EDS, with the highest prevalence among those with hEDS.

    “Nonetheless, in all studies with > 10 patients, the data are consistent with clinically important and statistically signi fi cant increases in the prevalence of orthostatic symptoms and objective hemodynamic abnormalities in those with joint hypermobility or EDS, with the highest prevalence being found among those with hEDS.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § A B S T R A C T · p. 1

    The review's literature search identified 10 relevant papers on the association between orthostatic intolerance or circulatory dysfunction and joint hypermobility or Ehlers-Danlos syndrome.

    “We identi fi ed 10 relevant papers.”
    • Also stated in: § 4. Association of orthostatic intolerance and circulatory dysfunction with JH/EDS · p. 3 · plain
      “The literature review identi fi ed 10 studies that addressed the association between various forms of circulatory dysfunction and JH or EDS.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given
    § 4.1. Literature summary · p. 4

    All published studies have enrolled patients who were being evaluated in academic medical centers or specialty clinics.

    “All published studies have enrolled patients who were being evaluated in academic medical centers or specialty clinics.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § 5.2.1. To accurately describe the clinical features of study populations · p. 7

    In a systematic review of 1006 people with joint hypermobility syndrome and 2951 controls, joint hypermobility was associated with higher odds of anxiety (OR 4.4) and panic disorder (OR 6.7).

    “In a large systematic review of 1006 with joint hypermobility syndrome and 2951 controls, those with joint hypermobility had higher odds of anxiety (OR =4.4) and panic disorder (OR = 6.7).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Smith et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § 5.2.3. To reduce enrollment of potential non-responders in treatment studies · p. 7

    People with hypermobile EDS are at higher risk of many comorbid problems, including gastrointestinal motility disorders, scoliosis, varicose veins, Chiari malformation, craniocervical instability and painful joint dislocation.

    “individuals with hEDS have a higher risk of a wide variety of co-morbid problems, including gastrointestinal motility disorders, scoliosis, varicose veins, Chiari malformation, craniocervical instability, painful joint dislocation, and others (Castori, 2012a; Zarate et al., 2010; Milhorat et al., 2007; Henderson et al., 2017).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Castori, 2012a

      Not checked in the free run.

    • cites Zarate et al., 2010 source

      Not checked in the free run.

    • cites Henderson et al., 2017 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning
    § 5.2.4. To prevent incorrect causal inferences · p. 7

    POTS confounds the relationship between joint hypermobility/hypermobile EDS and temporomandibular disorders, and the causal pathway runs from connective tissue laxity to both POTS and temporomandibular disorders rather than from dysautonomia to both.

    “we would suggest that POTS is a confounder for the relationship between joint hypermobility/hEDS and TMD, and that the true causal pathway leads from connective tissue laxity to both POTS and TMD, rather than from a dysautonomic state to both POTS”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation
    § 5.2.4. To prevent incorrect causal inferences · p. 7

    Durham and colleagues found that 17 of 36 adults with POTS (47%) had temporomandibular disorders.

    “They identi fi ed 17 (47%) as having TMD and concluded that this elevated prevalence ' adds further support to the conditions having a similar underlying dysautonomic pathophysiology. '”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Durham et al., 2015 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning
    § 5.2.1. To accurately describe the clinical features of study populations · p. 7

    Screening for joint hypermobility and hypermobile EDS can improve how study populations are described and let readers judge how representative the findings are.

    “Screening for JH and hEDS can improve the description of study populations and thereby allow readers to draw more accurate inferences about the representativeness of study fi ndings.”
    Quote in the paperNot a substantial claim
  • May combine two claims. The quote only partly states this claim.

    Interpretationnone given
    § 6. Conclusion · p. 7

    Some patients with hypermobile EDS experience frequent orthostatic symptoms that are linked to reduced quality of life.

    “A proportion with hEDS report frequent orthostatic symptoms that correlate with impairments”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation
    § 5.2.4. To prevent incorrect causal inferences · p. 7

    Other studies suggest joint hypermobility probably precedes and predisposes to both temporomandibular disorders and POTS.

    “Other studies, however, suggest that joint hypermobility likely precedes and predisposes to both TMD (De Coster et al., 2005; Kavuncu et al., 2005; Deodato et al., 2006; Pasinato et al., 2011) and POTS (Rowe et al., 1999).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites De Coster et al., 2005

      Not checked in the free run.

    • cites Kavuncu et al., 2005 source

      Not checked in the free run.

    • cites Rowe et al., 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.

    Interpretationnone given
    § M. Roma et al. · p. 8

    Paying more attention to how common joint hypermobility and EDS are among people with orthostatic intolerance could improve clinical care and make research results more valid.

    “Increased attention to the prevalence of joint hypermobility and EDS in those with orthostatic intolerance syndromes has the potential to improve clinical care and to enhance the validity of research results.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation
    § 5.1.3. To ensure provision of appropriate physical therapy care · p. 6

    Training protocols for patients with joint hypermobility must be adapted because of tissue fragility.

    “However, in patients with joint hypermobility, training protocols need to be adapted for tissue fragility (Engelbert et al., 2017).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Engelbert et al., 2017 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § 5.2.1. To accurately describe the clinical features of study populations · p. 7

    No patient with joint hypermobility had a viral infection as a POTS precipitant, versus 15% of the POTS-only group, a difference that was not statistically significant.

    “None of the JH patients had experienced a viral infection as a precipitant of POTS, compared to 15% of the POTS only group, but this di ff erence did not reach statistical signi fi cance.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Kanjwal et al., 2010

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § 5.2.1. To accurately describe the clinical features of study populations · p. 7

    The mean SF-36 physical function score was 55 in POTS and the median in hypermobile EDS was 35; bodily pain scores were 60 in POTS and 35 in hypermobile EDS.

    “The mean physical function subscale score was 55 in POTS and the median value in hEDS was 35, with lower scores indicating worse QOL.”
    • Also stated in: § 5.2.1. To accurately describe the clinical features of study populations · p. 7 · hedged
      “The bodily pain subscale scores also appear to di ff er substantially, 60 in POTS and 35 in hEDS.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Benrud-Larson et al., 2002 source

      Not checked in the free run.

    • cites Rombaut et al., 2010 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § 5.1.1. To improve general clinical management · p. 6

    People with EDS are at higher risk of spontaneous cerebrospinal fluid leaks, which can worsen headaches when upright.

    “Individuals with EDS have an increased risk of spontaneous cerebrospinal fl uid leaks, which in turn can contribute to worsening of headaches in positions of upright posture (Mokri et al., 2002).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Mokri et al., 2002 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § 5.2.1. To accurately describe the clinical features of study populations · p. 7

    Patients with both joint hypermobility and POTS presented at a significantly younger age and had more comorbid syncope (62% vs 30%) than those with isolated POTS.

    “Those with JH and POTS presented at a signi fi cantly younger age than those with isolated POTS and had a higher prevalence of co-morbid syncope (62 vs. 30%).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Kanjwal et al., 2010

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning
    § 4.1. Literature summary · p. 4

    It is unclear how much referral bias influences the findings.

    “It is therefore unclear how much referral bias in fl uences the fi ndings.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation
    § 5.2.4. To prevent incorrect causal inferences · p. 7

    The odds ratios for hypermobility syndromes in temporomandibular disorders were 11.2 for systemic joint hypermobility, 7.5 for localized condylar hypermobility and 15.3 for both, and the risk was significantly higher when both were present (P < 0.001).

    “The odds ratio for hypermobility syndromes in TMD were 11.2 for SJH, 7.5 for LCH and 15.3 for both.”
    • Also stated in: § 5.2.4. To prevent incorrect causal inferences · p. 7 · boosted
      “This study showed that the risk of TMD was signi fi cantly higher if both LCH and SJH were present (P &lt; 0.001).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Kavuncu et al., 2005 source

      Not checked in the free run.

18 of 18
  • The paper relies on this without support.

    EDS commonly involves chronic fatigue, and fatigue is a central symptom of several orthostatic intolerance syndromes.

    “EDS has long been recognized to be associated with a high prevalence of chronic fatigue, which in turn is a cardinal feature of various forms of orthostatic intolerance.”
  • The paper relies on this without support.

    Diagnosing joint hypermobility or EDS in patients with orthostatic intolerance matters to patients, clinicians, and researchers.

    “We discuss the importance to patients, clinicians, and researchers of making the diagnosis of joint hypermobility or EDS in patients who have orthostatic intolerance.”
  • The paper relies on this without support.

    The mechanism behind the higher prevalence of orthostatic intolerance in joint hypermobility and EDS is not well established.

    “The mechanism for the increased prevalence of orthostatic intolerance in joint hypermobility and EDS is not well established.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A review of studies found that orthostatic intolerance and tachycardia occurred in 35%-50% of patients with hypermobility spectrum disorder.

    “A review of studies that analyzed rates of POTS and other forms of orthostatic intolerance in patients with Ehlers–Danlos syndrome found that orthostatic intolerence and tachycardia occured in 35%–50% of patients with hypermobility spectrum disorder.24”

    From Diagnosis and management of postural orthostatic tachycardia syndrome (2022) · cites this paper as [24]

    The review reports postural tachycardia in 41% of patients with hypermobile EDS in one study and POTS in 49% of a joint hypermobility syndrome/hypermobile EDS group in another (section 4, p. 4). But it reports orthostatic intolerance at higher rates—74% and 80%, respectively—and does not establish a 35%–50% rate for both conditions in patients specifically diagnosed with hypermobility spectrum disorder. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Orthostatic intolerance is significantly more prevalent in individuals with joint hypermobility or hEDS and is often linked to postural tachycardia syndrome.

    “Orthostatic intolerance is significantly more prevalent in individuals with joint hypermobility or hEDS and is often linked to postural tachycardia syndrome [PoTS; (31)].”
  • Approximately 40% of POTS patients experience migraine, 20-30% meet criteria for hypermobile Ehlers-Danlos syndrome, and about 15% carry a diagnosis of co-morbid autoimmune disease.

    “Current estimates derived from small samples or uncontrolled survey data suggest that approximately 40% of POTS patients experience migraine, 20–30% meet the diagnostic criteria for hypermobile Ehlers-Danlos syndrome (Miller et al., 2020; Roma et al., 2018), and about 15% carry a diagnosis of a co-morbid autoimmune disease.”
  • Orthostatic intolerance and tachycardia can be found in up to 40% of patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome.

    “Conversely, orthostatic intolerance and tachycardia can be found in up to 40% of patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome (Miller et al., 2020; Roma et al., 2018).”
  • Many conditions such as mast cell activation disorders, Ehlers-Danlos syndrome, deconditioning, and genetic mutations of norepinephrine transporters coexist with POTS, and their downstream effects funnel into the three principal pathophysiologic mechanisms.

    “While many conditions, such as mast cell activation disorders (9), Ehlers-Danlos syndrome (10, 11), deconditioning (12), and genetic mutations of norepinephrine transporters (13), coexist with POTS, their downstream effects also funnel into these three principal pathophysiologic mechanisms.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Claim about all larger studies conflicts with a reported null comparison

    Minor

    The summary says every study with more than 10 patients found statistically significant increases, yet the paper later describes a 21-patient study that found no difference in orthostatic intolerance.

  • The stated range of hemodynamic abnormalities excludes a reported study

    Minor

    The summary gives an upper prevalence of 80%, but the earlier account says all 12 patients in the Rowe study had either POTS or isolated neurally mediated hypotension.

  • Valsalva noncompletion percentage uses the wrong denominator

    Minor

    The study group contains 35 adults, so 13 people represent 37.1%, not 31.4%.

    Reported 31.4 · recomputed 37.142857

  • Classical EDS is described as requiring generalized hypermobility despite an alternative criterion

    Minor

    The prose says both classical and hypermobile EDS require generalized joint hypermobility. Table 1 instead allows classical EDS to be diagnosed using three minor criteria in its place.

4 of 4

The citation lists haven’t been fetched yet

References 61 · Cited by 133

Research works printed but not linked: 26

  1. Barron, 2002, Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls, J. Pediatr., 141, 421, 10.1067/mpd.2002.127496 · DOI
  2. Beighton, 1973, Articular hypermobility in an African population, Ann. Rheum. Dis., 32, 413, 10.1136/ard.32.5.413 · DOI · Paper page
  3. Beighton, 1998, Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997, Am. J. Med. Genet., 77, 31, 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O · DOI · Paper page
  4. Blitshteyn, 2017, Cardiovascular testing in patients with postural tachycardia syndrome and Ehlers-Danlos syndrome type III, Clin. Auton. Res., 27, 117, 10.1007/s10286-017-0397-7 · DOI
  5. Byers, 2017, Diagnosis, natural history and management in vascular Ehlers-Danlos syndrome, Am. J. Med. Genet., 175, 40, 10.1002/ajmg.c.31553 · DOI · Paper page
  6. Castori, 2012, Surgical recommendations in Ehlers-Danlos syndrome(s) need patient classification: the example of Ehlers-Danlos syndrome hypermobility type (a.k.a. joint hypermobility syndrome), Dig. Surg., 29, 453, 10.1159/000346068 · DOI
  7. Cheng, 2016, Cardiovascular profile in postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome type III, Clin. Auton. Res., 27, 113, 10.1007/s10286-016-0392-4 · DOI
  8. De Coster, 2005, Generalized joint hypermobility and temporomandibular disorders: inherited connective tissue disease as a model with maximum expression, J. Orofac. Pain, 19, 47
  9. De Wandele, 2014, Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls, Semin. Arthritis Rheum., 44, 353, 10.1016/j.semarthrit.2014.05.013 · DOI · Paper page
  10. De Wandele, 2016, Orthostatic intolerance and fatigue in the hypermobility type of Ehlers-Danlos syndrome, Rheumatology (Oxford), 55, 1412, 10.1093/rheumatology/kew032 · DOI · Paper page
  11. Deodato, 2006, Predisposition for temporomandibular joint disorders: loose ligaments, Cranio, 24, 179, 10.1179/crn.2006.029 · DOI
  12. Durham, 2015, Painful temporomandibular disorders are common in patients with postural orthostatic tachycardia syndrome and impact significantly upon quality of life, J. Oral Facial Pain Headache, 29, 152, 10.11607/ofph.1396 · DOI · Paper page
  13. Grahame, 2000, The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS), J. Rheumatol., 27, 1777
  14. Henderson, 2017, Neurological and spinal manifestations of the Ehlers–Danlos syndromes, Am. J. Med. Genet. C Semin. Med. Genet., 175C, 195, 10.1002/ajmg.c.31549 · DOI · Paper page
  15. Kanjwal, 2010, Comparative clinical profile of postural orthostatic tachycardia patients with and without joint hypermobility syndrome, Indian Pacing Electrophysiol. J., 10, 173
  16. Mack, 2010, Orthostatic intolerance and the headache patient, Semin. Pediatr. Neurol., 17, 109, 10.1016/j.spen.2010.04.006 · DOI · Paper page
  17. Milhorat, 2007, Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and Chiari malformation type I in patients with hereditary disorders of connective tissue, J. Neurosurg. Spine, 7, 601, 10.3171/SPI-07/12/601 · DOI
  18. Pohl, 1988, Isoproterenol-induced panic attacks, Biol. Psychiatry, 24, 891, 10.1016/0006-3223(88)90224-7 · DOI · Paper page
  19. Pohl, 1990, Effects of isoproterenol in panic disorder patients after antidepressant treatment, Biol. Psychiatry, 28, 203, 10.1016/0006-3223(90)90575-M · DOI
  20. Rowe, 1995, Is neurally mediated hypotension an unrecognized cause of chronic fatigue?, Lancet, 345, 623, 10.1016/S0140-6736(95)90525-1 · DOI
  21. Russek, 2000, Examination and treatment of a patient with hypermobility syndrome, Phys. Ther., 80, 386, 10.1093/ptj/80.4.386 · DOI
  22. Simmonds, 2007, Hypermobility and the hypermobility syndrome, Man. Ther., 12, 298, 10.1016/j.math.2007.05.001 · DOI
  23. Simmonds, 2008, Hypermobility and the hypermobility syndrome, part 2: assessment and management of hypermobility syndrome: illustrated via case studies, Man. Ther., 13, e1, 10.1016/j.math.2007.11.001 · DOI
  24. Stewart, 1999, Orthostatic intolerance in adolescent chronic fatigue syndrome, Pediatrics, 103, 116, 10.1542/peds.103.1.116 · DOI
  25. Takenaka, 2002, Effects of rapid saline infusion on orthostatic intolerance and autonomic tone after 20 days bed rest, Am. J. Cardiol., 89, 557, 10.1016/S0002-9149(01)02296-2 · DOI · Paper page
  26. Van Dijk, 2008, Is fatigue in Marfan syndrome related to orthostatic intolerance?, Clin. Auton. Res., 18, 187, 10.1007/s10286-008-0475-y · DOI

Authors
Roma, M., Marden, C. L., De Wandele, I., Francomano, C. A., & Rowe, P. C.
Affiliations
Johns Hopkins University (US)
Corresponding author
  • Marden, Colleen L.
  • Francomano, Clair A.
  • Rowe, Peter C.
Venue
Autonomic Neuroscience
Publisher
Elsevier BV
Published
2018-12
Volume
215
Pages
89-96
ISSN
1566-0702 (ISSN-L)
OpenAlex
W2789331034
Cited by
133
References
61
Citations by year
2026: 12 · 2025: 12 · 2024: 21 · 2023: 8 · 2022: 21 · 2021: 34 · 2020: 13 · 2019: 8 · 2018: 3
FWCI
3.23
Type
journal article
Language
en
Open access
Locations
  • Autonomic Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
postural orthostatic tachycardia syndrome, orthostatic intolerance, Ehlers-Danlos syndrome, joint hypermobility, hereditary connective tissue disorders, autonomic dysfunction, cardiovascular dysfunction, quality of life, orthostatic challenge
MeSH terms
Ehlers-Danlos Syndrome, Humans, Joint Instability, Comorbidity, Syncope, Vasovagal, Postural Orthostatic Tachycardia Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review